biote Corp. (BTMDW) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Care Facilities industria. La empresa tiene su sede en Irving, TX, United States. El CEO actual es Marc D. Beer.
BTMDW tiene fecha de IPO 2022-05-27, cotiza en el Other OTC, una capitalización de mercado de $292.88M.
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
